Stocktoria
SIGA TECHNOLOGIES INC SIGA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1997-09-09
SIGA TECHNOLOGIES INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $94.6M | $138.7M | $139.9M | $110.8M | $133.7M |
| R&D expense | $20.0M | $12.3M | $16.4M | $22.5M | $9.9M |
| SG&A expense | $21.2M | $25.1M | $22.0M | $35.1M | $18.0M |
| Operating income | $23.7M | $70.0M | $83.6M | $42.7M | $89.1M |
| Interest expense | — | — | — | $0 | $0 |
| Income tax | $7.1M | $16.9M | $19.7M | $10.2M | $19.9M |
| Net income | $23.3M | $59.2M | $68.1M | $33.9M | $69.5M |
| EPS (diluted) | $0.32 | $0.82 | $0.95 | $0.46 | $0.91 |
| Operating cash flow | $43.5M | $48.8M | $94.8M | $41.6M | $11.5M |
| Cash & equivalents | $155.0M | $155.4M | $150.1M | $98.8M | $103.1M |
| Inventory | $49.1M | $49.6M | $64.2M | $39.3M | $19.5M |
| Total assets | $219.5M | $244.3M | $254.4M | $195.0M | $214.7M |
| Total liabilities | $20.6M | $28.5M | $57.5M | $24.9M | $40.4M |
| Shareholders' equity | $198.8M | $215.8M | $196.9M | $170.2M | $174.3M |
Source: SEC EDGAR filings · CIK 0001010086 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.